Raza Ali, Siraj Imrana, Malik Sabina, Mohammed Raji, Shariff Masood A
Surgical Oncology, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
Cancer Center Research Services, New York City (NYC) Health and Hospitals Corporation (HHC) Lincoln, Bronx, USA.
Cureus. 2023 Aug 25;15(8):e44095. doi: 10.7759/cureus.44095. eCollection 2023 Aug.
Fibrosarcoma is a rare, highly malignant tumor that develops from uncontrolled overgrowth of fibroblastic cells. It may start as a painless lump or swelling under the skin. But as it grows, it can push surrounding structures - organs, muscles, nerves, or blood vessels - and lead to pain and tenderness. The treatment of fibrosarcoma depends on several factors such as size, grade, location of primary tumor, extent of spread, age, and general health condition of the patient. The main treatment is surgical removal of the primary tumor with wide-margin excision and amputation if localized in the limb. Prior to surgical intervention, radiotherapy can be applied to reduce the tumor size or following surgery to lower the risk of recurrence. Chemotherapy is indicated in cases of metastasis. Unfortunately, the prognosis of fibrosarcoma is not favorable. For high-grade fibrosarcoma, the five-year survival rate is around 30% and for low-grade fibrosarcoma, it is 50-80%, with recurrence in the first two to five years post-surgery. We encountered a case of high-grade fibrosarcoma with aggressive growth in a 36-year-old male, requiring above-knee amputation.
纤维肉瘤是一种罕见的高度恶性肿瘤,由成纤维细胞不受控制地过度生长发展而来。它可能起初表现为皮肤下无痛的肿块或肿胀。但随着其生长,它会挤压周围结构——器官、肌肉、神经或血管——并导致疼痛和压痛。纤维肉瘤的治疗取决于几个因素,如肿瘤大小、分级、原发肿瘤位置、扩散程度、患者年龄和总体健康状况。主要治疗方法是手术切除原发肿瘤,若肿瘤局限于肢体则进行广泛切除和截肢。在手术干预前,可应用放疗来缩小肿瘤大小,或在手术后进行放疗以降低复发风险。发生转移的病例需进行化疗。不幸的是,纤维肉瘤的预后不佳。对于高级别纤维肉瘤,五年生存率约为30%,低级别纤维肉瘤的五年生存率为50 - 80%,术后头两到五年会复发。我们遇到一例36岁男性的高级别纤维肉瘤,生长侵袭性强,需要进行膝上截肢。